Max S Topp

5PUBLICATIONS
57CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 17, 2026
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

|Mar 26, 2026
Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel Therapy.

Sofie-Katrin Kadel, Lukas Scheller, Alexander M Leipold

|Jun 06, 2022
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study.

Michael Wang, Javier Munoz, Andre Goy

|Mar 18, 2021
Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia: Results of a pooled analysis.

Max S Topp, Anthony S Stein, Nicola Gökbuget

|Apr 04, 2020
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.

Michael Wang, Javier Munoz, Andre Goy

Pageof 1

Frequent Collaborators

2 joint publications

Michael Wang

2 joint publications

Hagop M Kantarjian

1 joint publications

Javier Munoz

1 joint publications

Andre Goy